Anti-science case study: COVID-19 vaccines' effectiveness and safety exaggerated.

作者信息

Lataster Raphael

机构信息

University of Sydney, Sydney, Australia.

出版信息

Public Health Pract (Oxf). 2024 May 23;7:100517. doi: 10.1016/j.puhip.2024.100517. eCollection 2024 Jun.

DOI:10.1016/j.puhip.2024.100517

PMID:38846110

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11153924/

Abstract

摘要

相似文献

[1]

Anti-science case study: COVID-19 vaccines' effectiveness and safety exaggerated.

Public Health Pract (Oxf). 2024-5-23

[2]

[Application of epidemiology research in evaluations of COVID-19 vaccines in both clinical trial and clinical use].

Zhonghua Liu Xing Bing Xue Za Zhi. 2022-1-10

[3]

Exploring future perspectives and pipeline progression in vaccine research and development.

Ann Ig. 2024

[4]

Who is "anti-science"?

Public Health Pract (Oxf). 2024-3-29

[5]

Efficacy and safety of mRNA and AstraZeneca COVID-19 vaccines in patients with autoimmune rheumatic diseases: A systematic review.

Vaccine. 2023-6-13

[6]

COVID-19 Vaccines' Protection Over Time and the Need for Booster Doses; a Systematic Review.

Arch Acad Emerg Med. 2022-7-4

[7]

Forty days of regulatory emergency use authorisation of COVID-19 vaccines: Interfacing efficacy, hesitancy and SDG target 3.8.

Glob Public Health. 2021-10

[8]

COVID-19 vaccine hesitancy among Israeli adults before and after vaccines' availability: A cross-sectional national survey.

Vaccine. 2022-10-12

[9]

Heterologous prime-boost strategies for COVID-19 vaccines.

J Travel Med. 2022-5-31

[10]

Effectiveness of inactivated COVID-19 vaccines against SARS-CoV-2 infections among healthcare personnel in Pakistan: a test-negative case-control study.

BMJ Open. 2023-6-27

引用本文的文献

[1]

What Lessons can Be Learned From the Management of the COVID-19 Pandemic?

Int J Public Health. 2025-5-30

[2]

Amid Growing Evidence of Conflicts of Interest and Obdurate Groupthink in Medical Journals, Researchers Must Entertain Contrarian Ideas.

Cureus. 2025-1-23

本文引用的文献

[1]

Who is "anti-science"?

Public Health Pract (Oxf). 2024-3-29

[2]

Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study.

Vaccine. 2024-4-2

[3]

COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals.

Vaccine. 2024-4-2

[4]

How the adverse effect counting window affected vaccine safety calculations in randomised trials of COVID-19 vaccines.

J Eval Clin Pract. 2024-4

[5]

How the case counting window affected vaccine efficacy calculations in randomized trials of COVID-19 vaccines.

J Eval Clin Pract. 2024-2

[6]

Reply to Fung et al. on COVID-19 vaccine case-counting window biases overstating vaccine effectiveness.

J Eval Clin Pract. 2024-2

[7]

Randomized clinical trials of COVID-19 vaccines: Do adenovirus-vector vaccines have beneficial non-specific effects?

iScience. 2023-5-19

[8]

Sources of bias in observational studies of covid-19 vaccine effectiveness.

J Eval Clin Pract. 2024-2

[9]

Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults.

Vaccine. 2022-9-22

[10]

Covid-19: Researcher blows the whistle on data integrity issues in Pfizer's vaccine trial.

BMJ. 2021-11-2

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Anti-science case study: COVID-19 vaccines' effectiveness and safety exaggerated.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献